Purple Biotech (Israel) Today
| KTOV Stock | ILA 20.50 0.50 2.50% |
Performance0 of 100
| Odds Of DistressOver 67
|
Purple Biotech is trading at 20.50 as of the 28th of April 2024, a 2.50% increase since the beginning of the trading day. The stock's open price was 20.0. Purple Biotech has more than 67 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Purple Biotech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of March 2024 and ending today, the 28th of April 2024. Click here to learn more.
Kitov Pharma Ltd, a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs. The company was formerly known as Kitov Pharmaceuticals Holdings Ltd. and changed its name to Kitov Pharma Ltd in January 2018. The company has 172.11 M outstanding shares. More on Purple Biotech
Moving against Purple Stock
| 0.42 | PZOL | Paz Oil | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Purple Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Purple Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Purple Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Itzhak Israel |
| Thematic Idea | IT (View all Themes) |
| Business Concentration | IT, Health Care, Pharmaceuticals, Biotechnology, Healthcare, Computing (View all Sectors) |
Purple Biotech (KTOV) is traded on Tel Aviv Stock Exchange in Israel and employs 9 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 227.01 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Purple Biotech's market, we take the total number of its shares issued and multiply it by Purple Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Purple Biotech operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 172.11 M outstanding shares.
Purple Biotech has accumulated about 63.01 M in cash with (5.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4.
Check Purple Biotech Probability Of Bankruptcy
Ownership AllocationPurple Biotech owns a total of 172.11 Million outstanding shares. Roughly 99.0 pct. of Purple Biotech outstanding shares are held by general public with 0.12 % owned by insiders and only 1.22 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Purple Ownership Details
Purple Stock Price Odds Analysis
What are Purple Biotech's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Purple Biotech jumping above the current price in 90 days from now is about 97.0%. The Purple Biotech probability density function shows the probability of Purple Biotech stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Purple Biotech has a beta of 0.1167. This indicates as returns on the market go up, Purple Biotech average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Purple Biotech will be expected to be much smaller as well. Additionally, purple Biotech has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Purple Biotech to move above the current price in 90 days from now is about 97.0 (This Purple Biotech probability density function shows the probability of Purple Stock to fall within a particular range of prices over 90 days) .
Purple Biotech Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Purple Biotech market risk premium is the additional return an investor will receive from holding Purple Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Purple Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Purple Biotech's alpha and beta are two of the key measurements used to evaluate Purple Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.82 | |||
| Standard Deviation | 5.5 | |||
| Variance | 30.25 | |||
| Risk Adjusted Performance | (0.06) |
Purple Stock Against Markets
Picking the right benchmark for Purple Biotech stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Purple Biotech stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Purple Biotech is critical whether you are bullish or bearish towards Purple Biotech at a given time. Please also check how Purple Biotech's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Purple Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Purple Biotech Corporate Directors
Purple Biotech corporate directors refer to members of a Purple Biotech board of directors. The board of directors generally takes responsibility for the Purple Biotech's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Purple Biotech's board members must vote for the resolution. The Purple Biotech board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Steven Steinberg | Independent Director | Profile | |
| Philip Serlin | Independent Director | Profile | |
| Arie Weber | Independent Director | Profile | |
| Ran Tzror | Independent Director | Profile |
How to buy Purple Stock?
Before investing in Purple Biotech, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Purple Biotech. To buy Purple Biotech stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Purple Biotech. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Purple Biotech stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Purple Biotech stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Purple Biotech stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Purple Biotech, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Purple Stock please use our How to Invest in Purple Biotech guide.
Already Invested in Purple Biotech?
The danger of trading Purple Biotech is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Purple Biotech is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Purple Biotech. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Purple Biotech is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Purple Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Purple Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Purple Biotech Stock. Highlighted below are key reports to facilitate an investment decision about Purple Biotech Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Purple Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Purple Stock refer to our How to Trade Purple Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Purple Stock analysis
When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |